Figure 1. Preparation of dual ligands and single ligand modified SLN/pEGFP.
Table 1. Particle size, zeta potential and gene-loading quantity of different vectors.
Figure 2. In vitro cytotoxicity evaluation of vectors in HepG2 cells.
Figure 3. In vivo transfection of vectors in HepG2 solid tumors bearing mice.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
